Adam, L; Bandyopadhyay, D; Kumar, R (2000) Interferon-alpha signaling promotes nucleus-to-cytoplasmic redistribution of p95Vav, and formation of a multisubunit complex involving Vav, Ku80, and Tyk2. Biochem Biophys Res Commun 267:692-6
|
Mandal, M; Bandyopadhyay, D; Goepfert, T M et al. (1998) Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK). Oncogene 16:217-25
|
Engelhardt, M; Kumar, R; Albanell, J et al. (1997) Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 90:182-93
|
Mandal, M; Maggirwar, S B; Sharma, N et al. (1996) Bcl-2 prevents CD95 (Fas/APO-1)-induced degradation of lamin B and poly(ADP-ribose) polymerase and restores the NF-kappaB signaling pathway. J Biol Chem 271:30354-9
|
Korutla, L; Kumar, R (1996) Inhibition of vesicular stomatitis virus replication by epidermal growth factor in human epidermoid A-431 cells. Biochem Biophys Res Commun 220:670-4
|
Zhu, X; Kumar, R; Mandal, M et al. (1996) Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci U S A 93:6091-5
|
Korutla, L; Kumar, R (1996) Mechanism of interferon action: in vivo activation of 91 kDa transcription factor. Anticancer Res 16:2789-95
|
Kumar, R; Mandal, M; Ratzkin, B J et al. (1996) NDF induces expression of a novel 46 kD protein in estrogen receptor positive breast cancer cells. J Cell Biochem 62:102-12
|
Kumar, R (1995) Dual modulation of phosphorylation of a 60 kDa nuclear protein in interferon-alpha treated Daudi cells. Biochem Biophys Res Commun 208:819-24
|
Kumar, R; Korutla, L (1995) Growth inhibition of human acute promyelocytic leukemia NB-4 cells by interferons and all-trans retinoic acid: trans-modulation of inducible gene expression pathways. Anticancer Res 15:353-60
|
Showing the most recent 10 out of 13 publications